Tab. 12.
Marketed, lipid-based oral solutions.
Marketed formulation | Active molecule | Dosage form | Manufacturer | Country of sale |
---|---|---|---|---|
Agenerase® | Amprenavir | Oral solution | GlaxoSmithKline | USA |
Sustiva® | Efavirenz | Oral solution | Bristol-Myers Squibb Company | USA |
Rocaltrol® | Calcitriol | Oral solution | Roche Laboratories Inc. | USA |